Literature DB >> 8777431

Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product.

K K Kim1, L Pajak, H Wang, L J Field.   

Abstract

Tuberous sclerosis (TS) is a genetically heterogeneous disease characterized by the widespread appearance of nonmalignant growths that affect multiple organ systems. A TS disease-determining gene, located at 16p13.3 and designated TSC2, has recently been cloned. In this report, the murine TSC2 homologue was cloned and characterized. cDNA clones encompassing the entire murine TSC2 transcript were isolated. Sequence analysis revealed a high degree of homology between the deduced amino acid sequence of the murine and human gene products. Northern blot surveys demonstrated widespread TSC2 expression which was subject to developmental regulation in a tissue-specific manner. Although high levels of TSC2 transcripts were observed in many adult tissues, protein analyses are required to determine whether functional tuberin protein is synthesized. Reverse transcription-polymerase chain reaction analyses identified at least six regions of alternative splicing, several of which modified putative regulatory motifs in the deduced amino acid structure of the TSC2 protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8777431

Source DB:  PubMed          Journal:  Cell Mol Biol Res        ISSN: 0968-8773


  3 in total

1.  Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog.

Authors:  T Kobayashi; S Urakami; J P Cheadle; R Aspinwall; P Harris; J R Sampson; O Hino
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

2.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

3.  Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.

Authors:  S Toyokuni; K Okada; S Kondo; H Nishioka; T Tanaka; Y Nishiyama; O Hino; H Hiai
Journal:  Jpn J Cancer Res       Date:  1998-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.